Monday November 23 2009 | Biotechnology feed | All feeds
|
|
ProXara Biotechnology Limited
Download detailed PDF Members: ProXara Biotechnology Limited is a recently-formed biotechnology company whose mission is to be a world leader in the development of novel therapeutically-relevant cell-based and in-vitro high throughput screens for drug discovery in the oncology field.The Company was founded by Professor Jeremy Tavaré in the Department of Biochemistry at the University of Bristol and was incorporated in March 2001. The company is supported by an experienced and entrepeneurial management team.ProXara has received funding from the Sulis Seedcorn Fund Partnership Limited, Catalyst BioMedica, The Wellcome Trust and private sources. Its premises are currently in the School of Medical Sciences in the University of Bristol
This page has been viewed 248 times since April 2007, the link to the organisation's website has been followed 69 times Search for more companies in Bristol This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for ProXara Biotechnology Limited | |||||||||||||||||||||||||||||||||||||||||
|